Ascentage Pharma to Present at J.P. Morgan Healthcare Conference
Ticker: AAPG · Form: 6-K · Filed: Dec 17, 2025 · CIK: 2023311
Sentiment: neutral
Topics: conference-presentation, press-release
TL;DR
Ascentage Pharma presenting at JPM Healthcare Conf on Dec 17, 2025. Big stage for them.
AI Summary
Ascentage Pharma Group International announced on December 17, 2025, that it will present at the 44th Annual J.P. Morgan Healthcare Conference. The company, located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China, will be filing this announcement as an Exhibit 99.1 with the SEC.
Why It Matters
Presentation at a major healthcare conference like J.P. Morgan's can increase visibility and attract potential investors or partners for Ascentage Pharma.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no immediate financial or operational impact disclosed.
Key Players & Entities
- Ascentage Pharma Group International (company) — Filer of the report
- J.P. Morgan Healthcare Conference (company) — Conference where Ascentage Pharma will present
- December 17, 2025 (date) — Date of the press release and announcement
- 68 Xinqing Road Suzhou Industrial Park Suzhou, Jiangsu China (location) — Principal executive offices of Ascentage Pharma
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report that Ascentage Pharma Group International issued a press release on December 17, 2025, announcing its participation in the 44th Annual J.P. Morgan Healthcare Conference.
When was the press release issued?
The press release was issued on December 17, 2025.
Which conference will Ascentage Pharma Group International be presenting at?
Ascentage Pharma Group International will be presenting at the 44th Annual J.P. Morgan Healthcare Conference.
Where are Ascentage Pharma Group International's principal executive offices located?
Ascentage Pharma Group International's principal executive offices are located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
What exhibit number is the press release furnished under?
The press release is furnished as Exhibit 99.1.
Filing Stats: 195 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2025-12-17 08:30:24
Filing Documents
- ea0269806-6k_ascent.htm (6-K) — 11KB
- ea026980601ex99-1_ascent.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-122549.txt ( ) — 25KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2025 Commission File Number: 001-42484 ASCENTAGE PHARMA GROUP INTERNATIONAL (Translation of Registrant’s name into English) 68 Xinqing Road Suzhou Industrial Park Suzhou, Jiangsu China (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On December 17, 2025, Ascentage Pharma Group International issued a press releases entitled “Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference”. A copy of the press release is furnished as Exhibit 99.1. 1 INDEX TO EXHIBITS Exhibit Number Exhibit Title 99.1 Press Release dated December 17, 2025 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ASCENTAGE PHARMA GROUP INTERNATIONAL Date: December 17, 2025 /s/ Dajun Yang Name: Dajun Yang Title: Chief Executive Officer 3